Osteosarcoma is the most common primary bone cancer in dogs, causing severe and rapidly progressive pain, and predominantly affects large and giant breeds in middle to old age.
Osteosarcoma imposes intense, progressive bone pain that severely compromises welfare — the tumour erodes cortical bone, causing microfractures and stimulating pain pathways that NSAIDs alone often fail to adequately control. Pain management requires multimodal approaches including NSAIDs, gabapentinoids, opioids, and bisphosphonates. The central welfare question for owners and vets is often not whether to treat aggressively, but how to maintain quality of life through the treatment course and know when that quality has deteriorated below an acceptable threshold. Palliative care — focusing on pain control, mobility, and enjoyment of daily activities — can provide genuinely good welfare outcomes over a meaningful time period. Honest prognosis discussions, structured quality of life assessments, and support for anticipatory grief are critical components of osteosarcoma care.